Literature DB >> 19273165

The role of chemokines in progressive renal disease.

Carla Zoja1, Pablo Bautista Garcia, Giuseppe Remuzzi.   

Abstract

Tubulointerstitial damage followed by scarring and progressive loss of renal function is common to many forms of chronic proteinuric nephropathies. The severity of tubulointerstitial injury and in particular interstitial macrophage infiltration strongly correlate with the risk of renal failure. Proteins filtered through the glomerular capillary in excessive amount activate proximal tubular cells to upregulate chemokines mainly via activation of NF-kappaB-dependent pathway. Chemokines secreted toward the basolateral compartment of tubular epithelial cells incite local recruitment of mononuclear cells, that in turn interact with resident renal cells and extracellular matrix to create a proinflammatory microenvironment that amplifies tubulointerstitial inflammation and promotes renal scarring. The association between proteinuria and interstitial accumulation of inflammatory cells via activation of transcription factors and overexpression of chemokines has been established both experimentally and in human proteinuric nephropathies. Blocking leukocyte recruitment by interfering with transcription factor activity or chemokines and their receptors is envisioned as a strategy to retard kidney disease progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273165     DOI: 10.2741/3343

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  13 in total

1.  Connections in chronic kidney disease: connexin 43 and connexin 37 interaction.

Authors:  Pedro A Jose; Shiyou Chen; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-27

2.  Renal impairment induced by prenatal exposure to angiotensin II in male rat offspring.

Authors:  Pavel Svitok; Monika Okuliarova; Ivan Varga; Michal Zeman
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-14

3.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

Review 4.  Molecular targets for treatment of kidney fibrosis.

Authors:  Peter Y Chuang; Madhav C Menon; John C He
Journal:  J Mol Med (Berl)       Date:  2012-11-22       Impact factor: 4.599

5.  Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.

Authors:  Nao Uchida; Yoshihiro Kushida; Masaaki Kitada; Shohei Wakao; Naonori Kumagai; Yasumasa Kuroda; Yoshiaki Kondo; Yukari Hirohara; Shigeo Kure; Gregorio Chazenbalk; Mari Dezawa
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

6.  Glomerular and tubular damage markers are elevated in patients with diabetes.

Authors:  Ferdau L Nauta; Wendy E Boertien; Stephan J L Bakker; Harry van Goor; Wim van Oeveren; Paul E de Jong; Henk Bilo; Ron T Gansevoort
Journal:  Diabetes Care       Date:  2011-02-09       Impact factor: 19.112

7.  GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice.

Authors:  Xu Yang; Shinji Kume; Yuki Tanaka; Keiji Isshiki; Shin-ichi Araki; Masami Chin-Kanasaki; Toshiro Sugimoto; Daisuke Koya; Masakazu Haneda; Takeshi Sugaya; Detian Li; Ping Han; Yoshihiko Nishio; Atsunori Kashiwagi; Hiroshi Maegawa; Takashi Uzu
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

8.  Detection of abnormal extracellular matrix in the interstitium of regenerating renal tubules.

Authors:  Will W Minuth; Lucia Denk
Journal:  Int J Mol Sci       Date:  2014-12-15       Impact factor: 5.923

9.  N-octanoyl-dopamine is an agonist at the capsaicin receptor TRPV1 and mitigates ischemia-induced [corrected] acute kidney injury in rat.

Authors:  Charalambos Tsagogiorgas; Johannes Wedel; Maximilia Hottenrott; Michael O Schneider; Uta Binzen; Wolfgang Greffrath; Rolf-Detlef Treede; Bastian Theisinger; Sonja Theisinger; Rüdiger Waldherr; Bernhard K Krämer; Manfred Thiel; Peter Schnuelle; Benito A Yard; Simone Hoeger
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

10.  Protection Effect of Zhen-Wu-Tang on Adriamycin-Induced Nephrotic Syndrome via Inhibiting Oxidative Lesions and Inflammation Damage.

Authors:  Chun-Ling Liang; Jun-Biao Wu; Jie-Mei Lai; Shu-Fang Ye; Jin Lin; Hui Ouyang; Janis Ya-Xian Zhan; Jiu-Yao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.